Published in Gut on May 01, 1999
Pathobiology of secondary immune thrombocytopenia. Semin Hematol (2009) 1.35
New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17
Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma. World J Gastroenterol (2004) 1.08
Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension. World J Gastroenterol (2007) 1.07
The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia. Hepat Med (2013) 0.84
Abnormal hematological indices in cirrhosis. Can J Gastroenterol (2009) 0.84
Pathobiology and treatment of hepatitis virus-related thrombocytopenia. Mediterr J Hematol Infect Dis (2009) 0.83
Usefulness of Noninvasive Predictors of Oesophageal Varices in Black African Cirrhotic Patients in Côte d'Ivoire (West Africa). Gastroenterol Res Pract (2012) 0.79
Effect of thrombopoietin on platelet counts and liver regeneration after partial hepatectomy in a rat model. Surg Today (2009) 0.78
Thrombin activation and liver inflammation in advanced hepatitis C virus infection. World J Gastroenterol (2016) 0.78
Perioperative use of allogenic blood components in live-related donor orthotopic liver transplantation: A cross sectional study. Asian J Transfus Sci (2013) 0.77
Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most? World J Hepatol (2015) 0.76
Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE. Dig Dis Sci (2007) 0.76
Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis. PLoS One (2016) 0.75
Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction. PLoS One (2015) 0.75
Dysfunction in Patients With Small-for-Size Grafts After Living Donor Liver Transplantation. Int Surg (2015) 0.75
Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature (1994) 3.13
Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest (1966) 2.43
Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature (1994) 2.41
Thrombokinetics in man. J Clin Invest (1969) 1.99
Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol (1996) 1.61
The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology (1996) 1.55
Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis. Thromb Haemost (1996) 1.51
Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol (1997) 1.12
Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology (1997) 1.11
Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci (1980) 1.09
Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg (1982) 1.08
Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med (1982) 1.05
Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med (1997) 1.03
Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg (1989) 0.99
Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol (1992) 0.93
Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice. Exp Hematol (1996) 0.92
Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol (1995) 0.89
Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest (1995) 0.86
The effect of massive liver resection on platelet kinetics in the rat. J Lab Clin Med (1975) 0.85
Regulation of hepatic thrombopoietin production by portal hemodynamics in liver cirrhosis. Am J Gastroenterol (1998) 0.84
Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation. J Hepatol (1994) 0.83
Thrombocytopenia after liver transplantation. Transplant Proc (1988) 0.81
Serum thrombopoietin levels following orthotopic liver transplantation. Thromb Haemost (1997) 0.79
Circulating thrombopoietin concentrations in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation. Br J Haematol (1996) 0.79
Thrombopoietin--clinically realized? N Engl J Med (1997) 0.78
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
Carcinoid tumour. Lancet (1998) 4.52
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther (2014) 3.98
Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol (1994) 3.44
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut (2005) 3.32
Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09
Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg (1988) 3.04
Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet (1979) 2.98
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev (2007) 2.75
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet (1978) 2.57
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol (2010) 2.50
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes (1997) 2.37
Bacterial infection in the pathogenesis of variceal bleeding. Lancet (1999) 2.35
The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant (2012) 2.29
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy (2006) 2.22
Coagulation and fibrosis in chronic liver disease. Gut (2008) 2.22
Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol (2001) 2.18
Systematic review and meta-analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg (2011) 2.13
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther (2006) 2.00
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet (1999) 1.98
"Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology (1998) 1.95
Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc (1979) 1.94
Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol (2002) 1.92
Liver transplantation in 100 children: Cambridge and King's College Hospital series. BMJ (1992) 1.90
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology (2002) 1.90
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther (2005) 1.86
Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology (1997) 1.86
Effects of caffeine on human health. Food Addit Contam (2003) 1.84
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78
Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. J Infect Dis (1997) 1.77
A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol (1999) 1.76
Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet (2000) 1.75
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med (1992) 1.72
Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet (1987) 1.68
Self-expanding metal stents for the palliation of dysphagia due to inoperable oesophageal carcinoma. Br J Surg (1995) 1.66
Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut (1998) 1.63
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev (2006) 1.63
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost (2010) 1.62
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol (1999) 1.60
Multidisciplinary approach to biliary complications of laparoscopic cholecystectomy. Br J Surg (1998) 1.59
Review article: portal vein thrombosis -- new insights into aetiology and management. Aliment Pharmacol Ther (2005) 1.59
Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology (1998) 1.57
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study. Aliment Pharmacol Ther (2013) 1.56
Oesophageal tuberculosis mimicking oesophageal carcinoma. Hong Kong Med J (2006) 1.53
Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry (2011) 1.52
Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil. Am J Transplant (2009) 1.52
The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation (1988) 1.51
Small hepatocellular carcinomas in cirrhotic explant livers: identification by macroscopic examination and lipiodol localization. Hepatology (1997) 1.48
Diurnal pattern of variceal bleeding in cirrhotic patients. J Hepatol (1993) 1.47
Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. Am J Transplant (2006) 1.47
Effective treatment of an elderly patient with Gaucher's disease and Parkinsonism: a case report of 24 months' oral substrate reduction therapy with miglustat. Parkinsonism Relat Disord (2006) 1.46
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther (2011) 1.46
Psychiatric and social outcome of liver transplantation. Br J Psychiatry (1995) 1.46
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Synaptology of trigemino- and spinothalamic lamina I terminations in the posterior ventral medial nucleus of the macaque. J Comp Neurol (2003) 1.45
U.S. suburbanization in the 1980s. Reg Sci Urban Econ (1998) 1.44
Bradyarrhythmias requiring pacemaker implantation after orthotopic heart transplantation: association with rejection. J Heart Lung Transplant (1992) 1.43
Safety and efficacy of indigenously developed and manufactured bivalirudin in moderate/high-risk Indian patients undergoing percutaneous coronary intervention: the Bivaflo Registry. Indian Heart J (2009) 1.42
A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT. Transfus Med (2010) 1.41
Systemic vasculitis with multiple aneurysms complicating systemic lupus erythematosus. J R Soc Med (1999) 1.41
Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long. Am J Transplant (2013) 1.40
Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients. Br J Radiol (2004) 1.40
Infection, coagulation, and variceal bleeding in cirrhosis. Gut (2005) 1.39
Staple-line erosion: a common source of recurrent bleeding following stapled oesophageal transection. Br J Surg (1991) 1.39
Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP. Environ Health Perspect (1982) 1.39
Acute limb ischaemia secondary to a collagen plug device. Eur J Vasc Endovasc Surg (2000) 1.39
Prolongation of canine pancreas allograft survival with cyclosporin A: preliminary report. Br Med J (1980) 1.38
Ultrasound screening for hepatocellular carcinoma (HCC) in cirrhosis: the evidence for an established clinical practice. Clin Radiol (1998) 1.38
Facial asymmetry with severe unilateral hypoplasia of the muscles of mastication: a report of clinical and electromyographic findings. Br J Oral Maxillofac Surg (1996) 1.38
Single-cell trisomy in hematologic malignancy. Random change or tip of the iceberg? Cancer Genet Cytogenet (1995) 1.38
Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A, -B, and -C acute hepatitis. J Med Virol (2002) 1.37
Spontaneous arteriovenous fistula between the common iliac vessels secondary to aneurysmal disease. J R Coll Surg Edinb (1990) 1.37
LeVeen shunt with wandering tip. Lancet (1991) 1.36
Recovery positive exercise stress test: an indication for coronary artery disease. J Assoc Physicians India (1994) 1.36
Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med (1982) 1.36
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2004) 1.35
Multiple myeloma: causes and consequences of delay in diagnosis. QJM (2007) 1.35
Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther (2009) 1.35
[Physical activity: results of the German Health Interview and Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2013) 1.35
Myristyl and palmityl acylation of the insulin receptor. J Biol Chem (1987) 1.34
Controversies in the management of bleeding esophageal varices (1) N Engl J Med (1989) 1.30
Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol (2006) 1.29
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology (1999) 1.29
Incidence, risk factors, management, and outcome of portal vein abnormalities at orthotopic liver transplantation. Transplantation (1994) 1.28